Multi-omics reveals that QKI-mediated NIN exon 18 splicing drives breast cancer cell progression
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Weiming Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA-Binding Proteins, Exons, Alternative Splicing. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Breast cancer is a leading cause of cancer-related mortality in women worldwide. Aberrant alternative splicing contributes to BRCA progression, but the role of splicing factors such as QKI and their regulation of specific splicing events, such as those in the NIN gene are poorly understood. Through multi-omics analysis of TCGA-BRCA data, we identified splicing factor QKI as a key regulator of the exon-skipping event NIN_ES_27495, which was significantly associated with poor patient prognosis. Mechanistically, QKI directly bound to NIN pre-mRNA and promoted exon 18 inclusion, generating the oncogenic isoform exon 18-included NIN isoform. Functional experiments demonstrated that depletion of exon 18-included NIN isoform suppressed proliferation, migration, and invasion in breast cancer cells, induced S-phase arrest using dysregulation of the CDK2/Cyclin A axis, and significantly inhibited tumor growth in vivo. These findings revealed that the QKI/exon 18-included NIN isoform axis is a critical driver of breast cancer progression, highlighting its potential as a therapeutic target for BRCA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.
- Department of Pharmacy, The Affiliated Huizhou Hospital, Guangzhou Medical University, Huizhou 516002, China. Electronic address: ytyt25yt@163.com.
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China. Electronic address: shenhanbc@163.com.
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Natural Science Foundation
Zitieren
APA
Chen, W., Liao, Z., He, Y., Wang, X., Zhen, J., Ye, T., & Shen, H. (2025). Multi-omics reveals that QKI-mediated NIN exon 18 splicing drives breast cancer cell progression. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112186
Vancouver
Chen W, Liao Z, He Y, Wang X, Zhen J, Ye T, et al. Multi-omics reveals that QKI-mediated NIN exon 18 splicing drives breast cancer cell progression. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112186
BibTeX
@article{Chen2025,
author = {Chen, Weiming and Liao, Zhiwei and He, Yingdi and Wang, Xuejia and Zhen, Jixuan and Ye, Ting and Shen, Han},
title = {Multi-omics reveals that QKI-mediated NIN exon 18 splicing drives breast cancer cell progression},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112186}
}
EUVIMED